GT Biopharma (GTBP) Metrics: History & Chart

GT Biopharma, Inc.(GTBP)

Biotechnology · San Francisco, CA

$6.38+0.22 (+3.57%)

Delayed quote: Oct 6, 2026, 1:59 PM EDT

About GT Biopharma, Inc.

GT Biopharma, Inc. is a biopharmaceutical company in the clinical development phase, dedicated to discovering and bringing to market novel immuno-oncology treatments. Their innovative approach centers on a proprietary technology platform called Tri-specific Killer Engager (TriKE) fusion proteins, which are designed to harness the body's immune cells. Central to their pipeline is GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate currently undergoing Phase I/II clinical trials. This therapeutic candidate is being evaluated for its potential in treating myelodysplastic syndromes, acute myeloid leukemia that has relapsed or proven refractory to prior treatments, advanced systemic mastocytosis, and other malignancies expressing CD33. The company's research also includes GTB-3650, which is in preclinical development targeting CD33 on myeloid leukemias, and GTB-5550, another preclinical asset aimed at solid tumors that are positive for B7-H3. GT Biopharma has forged key collaborations, including a co-development agreement with Altor BioScience Corporation for the clinical advancement of a 161533 TriKE fusion protein for various cancer indications. Furthermore, they maintain a license agreement with the Regents of the University of Minnesota to develop and commercialize cancer therapies utilizing their TriKE technology. Founded in 1965, the company previously operated as OXIS International, Inc. before rebranding to GT Biopharma, Inc. in July 2017. Its corporate operations are based in Brisbane, California.

San Francisco, CA

1 employees

www.gtbiopharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael Martin Breen

View full financials

Third-Party DCF Estimate (FMP)	$27.78
Price Gap vs Third-Party Estimate	+351.02%

7D Total Return	-9.73%
30D Total Return	+2.00%
YTD Total Return	-68.66%
1Y Total Return	-61.51%
3Y Total Return	-96.55%
5Y Total Return	-99.86%
10Y Total Return	-100.00%
15Y Total Return	N/A
20Y Total Return	N/A

2026	-68.66%
2025	-74.27%
2024	-60.13%
2023	-71.21%
2022	-70.96%
2021	-57.69%
2020

CAGR TTM	-61.33%
CAGR 3Y	-67.44%
CAGR 5Y	-73.13%
CAGR 10Y	-68.76%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	0.03
PE Ratio Avg TTM	0.17
PE Ratio Avg 3Y	0.17
Current VS TTM Avg	-82.70%
Current VS 3Y Avg	-82.70%
Current VS 5Y Avg	-82.70%

All Metrics

GTBP Valuation Metrics

GTBP Stock Price Metrics

GTBP Dividend Metrics

GTBP Growth Rate Metrics

GTBP Discounted Cash Flow Metrics

GTBP Returns By Period

GTBP Yearly Returns

GTBP Average Annual Returns By Period (CAGR)

GTBP Revenue Metrics

GTBP PE Ratio Metrics

GTBP PS Ratio Metrics

GTBP PB Ratio Metrics

GTBP Price to Free Cash Flow Ratio Metrics

GTBP Debt to Equity Ratio Metrics

GTBP PEG Ratio Metrics

GTBP FCF Yield

GTBP Earnings Yield

GTBP EBITDA Yield

GTBP OCF Yield

GTBP EV/EBIT Ratio Metrics

GTBP EV/EBITDA Ratio Metrics

GTBP EV/Assets Ratio Metrics

GTBP EV/Sales Ratio Metrics

GTBP Current Ratio Metrics

GTBP Quick Ratio Metrics

GTBP ROIC Metrics

GTBP Return on Assets Metrics

GTBP Return on Equity Metrics

GTBP Net Profit Margin Metrics

GTBP Gross Profit Margin Metrics

GTBP Tax Rate Metrics

PS Ratio	1262.12
PS Ratio Avg TTM	851.62
PS Ratio Avg 3Y	851.62
Current VS TTM Avg	+48.20%
Current VS 3Y Avg	+48.20%
Current VS 5Y Avg	+48.20%

PB Ratio	2.68
PB Ratio Avg TTM	1.19
PB Ratio Avg 3Y	0.86
Current VS TTM Avg	+125.87%
Current VS 3Y Avg	+212.08%
Current VS 5Y Avg	+42.74%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	N/A
Current VS 3Y Avg	-100.00%
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	3616.23%
Earnings Yield Avg TTM	1059.05%
Earnings Yield Avg 3Y	1046.20%
Current VS TTM Avg	+241.46%
Current VS 3Y Avg	+245.65%
Current VS 5Y Avg	+245.65%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.80
Ev/Assets Ratio Avg TTM	0.42
Ev/Assets Ratio Avg 3Y	0.31
Current VS TTM Avg	+88.28%
Current VS 3Y Avg	+160.34%
Current VS 5Y Avg	-31.06%

Ev/Sales Ratio	4677.45
Ev/Sales Ratio Avg TTM	2618.99
Ev/Sales Ratio Avg 3Y	2618.99
Current VS TTM Avg	+78.60%
Current VS 3Y Avg	+78.60%
Current VS 5Y Avg	+78.60%

Current Ratio	2.61
Current Ratio Avg TTM	3.12
Current Ratio Avg 3Y	2.47
Current VS TTM Avg	-16.30%
Current VS 3Y Avg	+5.68%
Current VS 5Y Avg	-6.95%

Quick Ratio	2.61
Quick Ratio Avg TTM	3.12
Quick Ratio Avg 3Y	2.47
Current VS TTM Avg	-16.30%
Current VS 3Y Avg	+5.68%
Current VS 5Y Avg	-6.95%

ROIC	(457.75%)
ROIC Avg 3Y	(277.04%)
ROIC Avg 5Y	(196.41%)
Current VS 3Y Avg	-65.23%
Current VS 5Y Avg	-133.06%
Current VS 10Y Avg	-153.14%

ROA	(381.53%)
ROA Avg TTM	(124.39%)
ROA Avg 3Y	(38.51%)
Current VS TTM Avg	-206.72%
Current VS 3Y Avg	-890.75%
Current VS 5Y Avg	-1109.21%

ROE	(618.74%)
ROE Avg TTM	(742.02%)
ROE Avg 3Y	(455.92%)
Current VS TTM Avg	+16.61%
Current VS 3Y Avg	-35.71%
Current VS 5Y Avg	-80.91%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A